This article is available to subscribers. Subscribe now. Already have an account? Sign in

Original ArticleFree PreviewArchive

A Twenty-Five-Year Follow-up Study of Women Exposed to Diethylstilbestrol during Pregnancy

List of authors.
  • Marluce Bibbo, M.D.,
  • William M. Haenszel, DR.P.H.,
  • George L. Wied, M.D.,
  • Marian Hubby, Ph.D.,
  • and Arthur L. Herbst, M.D.

Abstract

Abstract

To assess the long-term effects of diethylstilbestrol we conducted a health survey among 693 mothers who had taken the drug during pregnancy and a comparable group of 668 who had not. These women had participated in a study during 1951–52 to evaluate the drug. There were 32 (4.6 per cent) breast cancers among the 693 exposed and 21 (3.1 per cent) among the 668 unexposed, but the difference was not statistically significant (P = 0.16). No statistically significant differences occurred between the groups in any of the other categories of disease. The occurrence of breast cancer in both groups was compared to the Connecticut State Tumor Registry for 1963–65. Compared to the registry data, a significantly (P<0.01) higher incidence of breast cancer occurred in both the exposed and unexposed groups at ages over 50. The reason for this increase is not known, but effects linked to the selection of mothers participating in the original clinical study cannot be excluded. (N Engl J Med 298:763–767, 1978)

Funding and Disclosures

Supported by a contract (NIH-N01–4–2850) with the National Institute of Child Health and Human Development.

Author Affiliations

From the departments of Obstetrics and Gynecology and Pathology, University of Chicago, and the Illinois Cancer Council (address reprint requests to Dr. Bibbo at HM #449, 5841 S. Maryland Ave., Chicago, IL 60637).

Print Subscriber? Activate your online access.